(Q38162354)

30 August 2017

title

A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds (English)

1 reference

30 August 2017

0 references

Benoît Bertrand

1

0 references

Angela Casini

object named as

Angela Casini

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 March 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

43

1 reference

30 August 2017

issue

11

1 reference

30 August 2017

page(s)

4209-4219

1 reference

Excursions in polynuclear platinum DNA binding

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

A categorization of metal anticancer compounds based on their mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Anti-cancer potential of gold complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Molecular mechanisms and proposed targets for selected anticancer gold compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Noble metal-dithiocarbamates precious allies in the fight against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Gold compounds as therapeutic agents for human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Cysteine proteases as targets for metal-based drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Deubiquitinases as potential anti-cancer targets for gold(III) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Deubiquitinases in cancer: new functions and therapeutic options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Gold(I)-mediated inhibition of protein tyrosine phosphatases: a detailed in vitro and cellular study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Cyclometalation using d-block transition metals: fundamental aspects and recent trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Metal compounds for the treatment of parasitic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

A dual cytotoxic and anti-angiogenic water-soluble gold(III) complex induces endoplasmic reticulum damage in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Iminophosphorane-organogold(III) complexes induce cell death through mitochondrial ROS production

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Synthesis of apoptosis-inducing iminophosphorane organogold(III) complexes and study of their interactions with biomolecular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Solution chemistry and cytotoxic properties of novel organogold(III) compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Organogold(III) supramolecular polymers for anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

N-Heterocyclic carbene metal complexes in medicinal chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Mitochondrial permeability transition induced by dinuclear gold(I)-carbene complexes: potential new antimitochondrial antitumour agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Role of membrane potential in the regulation of cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Fluorescent silver(I) and gold(I)-N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Structure, mechanism and regulation of peroxiredoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Synthesis, characterization, and in vitro studies of bis[1,3-diethyl-4,5-diarylimidazol-2-ylidene]gold(I/III) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

The application of DNA and RNA G-quadruplexes to therapeutic medicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Chemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

G-quadruplex nucleic acids as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Cyclometalated gold(III) complexes with N-heterocyclic carbene ligands as topoisomerase I poisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Cationic gold(I) heteroleptic complexes bearing a pyrazole-derived N-heterocyclic carbene: syntheses, characterizations, and cytotoxic activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Gold(I)-NHC complexes of antitumoral diarylimidazoles: structures, cellular uptake routes and anticancer activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Applications of gold(I) alkynyl systems: a growing field to explore

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Metal alkynyl sigma complexes: synthesis and materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Synthesis and biological studies of some gold(I) complexes containing functionalised alkynes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Antitumor activity of diethynylfluorene derivatives of gold(I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

On the biological properties of alkynyl phosphine gold(I) complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Isolation of neutral mono- and dinuclear gold complexes of cyclic (alkyl)(amino)carbenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(iii) compounds studied with combined mass spectrometry and biochemical assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Reactions of gold(III) complexes with serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Medicinal gold compounds form tight adducts with the copper chaperone Atox-1: biological and pharmacological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

A dinuclear cyclometalated gold(iii)–phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

Luminescent cyclometalated gold(iii) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT52524D

21 January 2018

Identifiers

DOI

10.1039/C3DT52524D

1 reference

30 August 2017

1 reference